Antibodies to GM1(NeuGc) in Guillain-Barre syndrome after ganglioside therapy

Journal of the Neurological Sciences

Volumn 175, Issue 2, 2000, Pages 96-106

  Odaka, Masaaki ^a   Yuki, Nobuhiro ^a   Nobile Orazio, Eduardo ^b,c   Carpo, Marinella ^b,c   Hirata, Koich ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MILAN   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

Anti ganglioside antibody; GM1; GM1b; Guillain Barre syndrome; N Glycolylneuraminic acid

Indexed keywords

ANTIGEN; CHOLERA TOXIN; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOTETRAOSYLCERAMIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; N GLYCOLOYLNEURAMINIC ACID;

ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; BRAIN; CATTLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONATION; GUILLAIN BARRE SYNDROME; HUMAN; ITALY; JAPAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODY FORMATION; CATTLE; CHROMATOGRAPHY, THIN LAYER; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; G(M1) GANGLIOSIDE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; MASS SPECTROMETRY;

EID: 0034655910     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00287-2     Document Type: Article

References (41)

1. Latov N., Koski C.L., Walicke P.A. Guillain-Barré syndrome and parenteral gangliosides. Lancet. 338:1991;757.
2. Figueras A., Morales-Olivas F.J., Capellà D., Palop V., Laporte J.-R. Bovine gangliosides and acute motor polyneuropathy. Br Med J. 305:1992;1330-1331.
3. Nobile-Orazio E., Carpo M., Meucci N., Grassi M.P., Capitani E., Sciacco M., Mangoni A., Scarlato G. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci. 109:1992;200-206.
4. Landi G., D'Alessandro R., Dossi B.C., Ricci S., Simone I.L., Ciccone A. Guillain-Barré syndrome after exogenous gangliosides in Italy. Br Med J. 307:1993;1463-1464.
5. Illa I., Ortiz N., Gallard E., Juarez C., Grau J.M., Dalakas M.C. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol. 38:1995;218-224.
6. Govoni V., Granieri E., Tola M.R., Paolino E., Casetta I., Fainardi E., Monetti V.C. Exogenous gangliosides and Guillain-Barré syndrome: an observational study in the Local Health District of Ferrara, Italy. Brain. 120:1997;1123-1130.
7. Ilyas A.A., Willison H.J., Quarles R.H., Jungalwala F.B., Cornblath D., Trapp B.D., Griffin D.E., Griffin J.W., McKhann G.M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol. 23:1988;440-447.
8. Svennerholm L., Fredman P. Antibody detection in Guillain-Barré syndrome. Ann Neurol. 27:(Suppl):1990;s36-40.
9. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 40:1990;1900-1902.
10. Nowak J.A., Jain N.K., Stinson M.W., Merrick J.M. Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a human Hanganutziu-Deicher serum. Mol Immunol. 23:1986;693-700.
11. Kawachi S., Saida T. Analysis of the expression of Hanganutziu-Deicher (HD) antigen in human malignant melanoma. J Dermatol. 19:1992;827-830.
12. Kato S., Higashi H. N-Glycolylneuraminic acid-containing glycoconjugates: a new tumor associated cell surface antigen known as Hanganutziu-Deicher antigen. Gann Monogr Cancer Res. 34:1988;41-50.
13. Merrick J.M., Zadarlik K., Milgrom F. Characterization of the Haganutziu-Deicher (serum-sickness) antigen as gangliosides containing N-glycolylneuraminic acid. Int Arch Allergy Appl Immunol. 57:1978;477-480.
14. Odaka M., Yuki N., Yoshino H., Kasama T., Handa S., Irie F., Hirabayashi Y., Suzuki A., Hirata K. N-Glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol. 43:1998;829-834.
15. Walsh F.S., Cronin M., Koblar S., Doherty P., Winer J., Leon A., Hughes R.A.C. Association between glycoconjugate antibodies and Campylobacter [sic] infection in patients with Guillain-Barré syndrome. J Neuroimmunol. 34:1991;43-51.
16. Yuki N., Yoshino H., Sato S., Shinozawa K., Miyatake T. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve. 15:1992;899-903.
17. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 43:1993;1911-1917.
18. Kusunoki S., Chiba A., Kon K., Ando S., Arisawa K., Tate A., Kanazawa I. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol. 35:1994;570-576.
19. Kusunoki S., Iwamori M., Chiba A., Hitoshi S., Arita M., Kanazawa I. GM1b is a new member of [sic] antigen for serum antibody in Guillain-Barré syndrome. Neurology. 47:1996;237-242.
20. Yuki N., Taki T., Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol. 71:1996;155-161.
21. Yuki N., Tagawa Y., Irie F., Hirabayashi Y., Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α J Neuroimmunol. 74:1997;30-34.
22. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 39:1996;668-672.
23. Hirabayashi Y., Nakao T., Matsumoto M., Obata K., Ando S. Improved method for large-scale purification of brain gangliosides by Q-Sepharose column chromatography: immunochemical detection of C-series polysialogangliosides in adult bovine brains. J Chromatogr. 445:1988;377-384.
24. Nakamura K., Suzuki M., Inagaki F., Yamakawa T., Suzuki A. A new ganglioside showing choleragenoid-binding activity in mouse spleen. J Biochem. 101:1987;825-835.
25. Fishman P.H., Pacuszka T., Hom B., Moss J. Modification of ganglioside GM1: effect of lipid moiety on choleragen action. J Biol Chem. 255:1980;7657-7664.
26. Hirabayashi Y., Suzuki T., Suzuki Y., Taki T., Matsumoto M., Higashi H., Kato S. A new method for purification of anti-glycosphingolipid antibody: avian anti-hematoside (NeuGc) antibody. J Biochem (Tokyo). 94:1983;327-330.
27. Taki T., Ishikawa D. TLC blotting: application to microscale analysis of lipids and as a new approach to lipid-protein interaction. Anal Biochem. 251:1997;135-143.
28. Kasama T., Handa S. Structural studies of gangliosides by fast atom bombardment ionization, low-energy collision-activated dissociation, and tandem mass spectrometry. Biochemistry. 30:1991;5621-5624.
29. Naiki M., Higashi H. Detection of antibodies to gangliosides in pathologic human sera: serum-sickness type heterophile antibodies. Adv Exp Med Biol. 125:1980;359-367.
30. Ikuta K., Nishi Y., Shimizu Y., Higashi H., Kitamoto N., Kato S., Fujita M., Nakano Y., Taguchi T., Naiki M. Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence. Biken J. 25:1982;47-50.
31. Sheikh K.A., Deerinck T.J., Ellisman M.H., Griffin J.W. The distribution of ganglioside-like moieties in peripheral nerves. Brain. 122:1999;449-460.
32. Ala T.A., Perfetti P.A., Frey W.H. 2nd. Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptoms. J Neuroimmunol. 53:1994;109-113.
33. Neisser A., Schwerer B., Bernheimer H., Moran A.P. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome. J Neuroimmunol. 102:2000;85-88.
34. Harvey G.K., Toyka K.V., Zielasek J., Kiefer R., Simonis C., Hartung H.P. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve. 18:1995;388-394.
35. Hirota N., Kaji R., Bostock H., Shindo K., Kawasaki T., Mizutani K., Oka N., Kohara N., Saida T., Kimura J. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain. 120:1997;2159-2169.
36. Santoro M., Uncini A., Corbo M., Staugaitis S.M., Thomas F.P., Hays A.P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol. 31:1992;385-390.
37. Arasaki K., Kusunoki S., Kudo N., Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve. 16:1993;587-593.
38. Uncini A., Santoro M., Corbo M., Lugaresi A., Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve. 16:1993;610-615.
39. + currents in isolated rat myelinated nerve fibers. Ann Neurol. 37:1995;436-442.
40. Roberts M., Willison H.J., Vincent A., Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol. 38:1995;111-118.
41. Thomas F.P., Trojaborg W., Nagy C., Santoro M., Sadiq S.A., Latov N., Hays A.P. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 82:1991;378-383.